Abstract
Bone marrow-derived mesenchymal stem cells (MSCs) reduce acute lung injury in animals challenged by bleomycin or bacterial lipopolysaccaride. It is not known, however, whether MSCs protect from ventilator-induced lung injury (VILI).
Whether MSCs have a potential role in preventing or modulating VILI in healthy rats subjected to high-volume ventilation.
24 Sprague-Dawley rats (250–300 g) were subjected to high-volume mechanical ventilation (25 mL·kg−1). MSCs (5×106) were intravenously or intratracheally administered (N=8 each) 30 min before starting over-ventilation and 8 rats were MSC-untreated. Spontaneously breathing anesthetised rats (N=8) served as controls. After 3 h of over-ventilation/control the animals were sacrificed and lung tissue and bronchoalveolar lavage fluid (BALF) were sampled for further analysis.
When compared with controls, MSC-untreated over-ventilated rats exhibited typical VILI features. Lung oedema , histological lung injury index, concentrations of total protein, interleukin-1β, macrophage inflammatory protein-2 and number of neutrophils in BALF and vascular cell adhesion protein-1 in lung tissue significantly increased in overventilated rats. All these indices of VILI moved significantly towards normalization in the rats treated with MSCs, whether intravenously or intratracheally.
Both local and systemic pre-treatment with MSCs reduced VILI in a rat model.
- Acute lung injury
- cell therapy
- injurious ventilation
- lung oedema
- lung inflammation
- mechanical ventilation
- ERS
